Companies: 10,795·Total market cap: $144.5T
Immunocore Holdings plc

Immunocore Holdings plc

IMCRNASDAQHealthcare● Active
$27.79
$-0.51(-1.79%)
Market Cap$1.4B
P/E Ratio
52W High$40.715
52W Low$27.555
Overview

Immunocore Holdings plc (IMCR) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

imcr · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 14 Wall Street analysts in the past 3 months

SellBuy

Buy

14 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
9
Hold
5
Sell
0
Strong Sell
0
Total: 14 · Buy rate: 64.3%

12-Month Price Target

High

$55.00

Consensus

$46.50

+67.0% upside

Low

$38.00

Median: $46.5 · Last Close: $27.84

The Immunocore Holdings plc (IMCR) analyst consensus is Buy, based on ratings from 14 Wall Street analysts over the past 3 months. The average 12-month IMCR price target is $46.50, representing +67.0% upside from the current price of $27.84.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Historical priceConsensus $47 (67.0%)

Consensus Target

$46.50

67.0% upside

High Target

$55

97.6%

Low Target

$38

36.5%

Current Price

$27.84

as of today

Based on analyst price targets, the IMCR stock price prediction for the next 12 months ranges from $38 to $55. The consensus IMCR price forecast of $46.50 implies 67.0% upside from the current price of $27.84.

Short-Term Price Prediction

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$27.680.59%

1-day model range: $27.56–$27.79. Peak: $27.79 (-0.59%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027$17-39.4%
2028$13-52.5%
2029$12-58.1%
2030$11-60.9%
2031-62.3%
Confidence:Medium

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

Market Sentiment

BEARISH

Based on 14 technical indicators

0%7%93%
0Buy
1Neutral
13Sell
RSI (14)46.4Neutral
MACDBEARISH

Refreshes daily from EOD close

Moving Averages · IMCR · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$28.62SELL
MA 10$28.80SELL
MA 20$28.88SELL
MA 50$29.66SELL
MA 100$31.03SELL
MA 200$32.92SELL
Current $IMCR · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$28.42SELL
EMA 10$28.68SELL
EMA 20$28.92SELL
EMA 50$29.66SELL
EMA 100$30.78SELL
EMA 200$31.99SELL
Current $IMCR · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
HC Wainwright & Co.2026-04-20
Maintains
BuyBuy
HC Wainwright & Co.2026-04-14
Maintains
BuyBuy
Jefferies2026-03-16
Downgrade ↓
BuyHold
Needham2026-02-26
Maintains
BuyBuy
HC Wainwright & Co.2026-02-04
Maintains
BuyBuy
Morgan Stanley2025-11-10
Maintains
Equal WeightEqual Weight
HC Wainwright & Co.2025-10-22
Maintains
BuyBuy
HC Wainwright & Co.2025-06-02
Maintains
BuyBuy
Oppenheimer2025-05-08
Maintains
OutperformOutperform
JP Morgan2025-04-14
Maintains
OverweightOverweight

Wall Street analysts have recently issued updated ratings on Immunocore Holdings plc (IMCR) stock. Of the recent 84 rating actions, 1 were upgrades and 4 were downgrades. 14 analysts currently cover IMCR.

Analyst Recommendation Trends

Buy ratings12↑ +1
Hold ratings00
Sell ratings00

IMCR analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 2 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$448M

↓ 22.7% YoY

Revenue Next Year

$486M

↑ 8.5% YoY

EPS This Year

$0.12

EPS Next Year

$-0.50

↓ 520.8% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast IMCR EPS of $0.12 for the current fiscal year, based on estimates from 10 analysts. The IMCR revenue forecast is $448M for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The IMCR stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus IMCR price target is $46.50 (+67.0% upside), with an analyst consensus of Buy.

The IMCR short-term stock prediction for tomorrow is $27.68 (-0.59%). The IMCR stock price prediction for 2027 estimates an average of $17. The IMCR stock prediction for 2030 projects a range of $10–$11.

Immunocore Holdings plc trades on NASDAQ under the ticker IMCR. The IMCR stock outlook for 2027 is broadly positive, supported by a Buy consensus among 64% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

IMCR forecast · 8 questions

According to 14 Wall Street analysts, the average 12-month IMCR price target is $46.50, with a high forecast of $55.00 and a low of $38.00. The median price target is shown in the chart above when available. This implies +67.0% potential upside from the current price of $27.84.

IMCR price targetWhat is IMCR price targetIMCR analyst price targetIMCR 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.